Exploring rare variant subtypes of bladder tumors | 2023 Bladder Cancer Advocacy Network Think Tank

Co-chairs Roger Li, MD, Moffit Cancer Center and Karima Oualla, MD, MSc, Hassan II University Hospital, Morocco The newly formed IBCG-GSRGT Joint Committee on rare variants of bladder tumor, brings together stakeholders to collaborate on research, education, and clinical trial endpoints with a focus on bladder cancer variants. Join the discussion to identify knowledge gaps in the biological, genomic and clinical features related to various bladder cancer variants, immediate unmet needs, and ways to overcome these challenges. We hope to engender interest and form a global coalition to accelerate progress in this field. Invited discussion leaders: Philippe E Spiess, MD, MS, FACS, FRCS(C), Moffitt Cancer Center Ashish M. Kamat, MD, University of Texas MD Anderson Cancer Center Rafee Talukder, MD, Fred Hutch Cancer Center Samuel A. Funt, MD, Memorial Sloan Kettering Cancer Center Hikmat Al-Ahmadie, MD, Memorial Sloan Kettering Cancer Center Francesca Khani, MD, Weill Cornell Medicine